Aristotle University Of Thessaloniki (AUTH)
Συσχέτιση πολυμορφισμών (SNPs) στο γονίδιο SLC19A1 και σε ρυθμιστικά του miRNAs με την τοξικότητα της μεθοτρεξάτης σε παιδιά με οξεία λεμφοβλαστική λευχαιμία
Abstract
dc:descriptionAim: Methotrexate (MTX) is an anti-folate chemotherapeutic agent that is considered to be a gold standard in Acute Lymphoblastic Leukemia (ALL) therapy. Although ΜΤΧ brings together a set of features that make it an essential choice for ALL treatment, the administration of mainly high doses of MTX has been associated with toxicities. To date, the pathogenesis of these MTX induced toxicities is not completely understood. MTX pharmacogenetics implicate various genes as predictors of MTX toxicity, especially those who participate in the MTX intake like the solute carrier family 19 member 1 (SLC19A1). The aim of the present study was to evaluate the association between SLC19A1 polymorphisms and its regulatory miRNAs with MTX toxicity in children with ALL. Methods: A total of 86 children with ALL participated in this study. All patients were included in the same chemotherapy protocol and had been diagnosed and treated at the Pediatric and Adolescent Hematology and Oncology Unit of the Second Pediatric Clinic of the AHEPA University Hospital of Thessaloniki. Total peripheral blood was isolated from all participants and genotyping was performed for rs2838958, rs1051266 and rs1131596 SLC19A1 polymorphisms as well as rs56292801 polymorphism of miR-5189. Patients were followed up (24, 42 and 48 hours) after treatment with MTX in order to evaluate the presence of MTX-associated adverse events. Results: Our results indicate that there is a statistically significant correlation between rs1131596 SLC19A1 polymorphism and the development of MTX-induced hepatotoxicity (P=0.03) but there is no significant association between any of the studied polymorphisms and mucositis or other side effects such as nausea, emesis, diarrhea, neutropenia, skin rash and infections. In addition, when genotype TT of rs1131596 and genotype AA of rs56292801 are both present in a patient then there is a higher risk in developing severe hepatotoxicity (p=0.0104).
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karpa, Vasiliki
- Καρπά, Βασιλική
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58902